C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics

• Vasilios Devetzis,

  Affiliation Department of Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital, Bern, Switzerland

  ⨯
• Arezoo Daryadel,

  Affiliation Institute of Physiology, University of Zurich, Zurich, Switzerland

  ⨯
• Stefanos Roumeliotis,

  Affiliation Department of Nephrology, University Hospital of Alexandroupoli, Alexandroupoli, Greece

  ⨯
• Marios Theodoridis,

  Affiliation Department of Nephrology, University Hospital of Alexandroupoli, Alexandroupoli, Greece

  ⨯
• Carsten A. Wagner,

  Affiliation Institute of Physiology, University of Zurich, Zurich, Switzerland

  ⨯
• Stefan Hettwer,

  Affiliation Neurotune AG, Schlieren, Switzerland

  ⨯
• Uyen Huynh-Do,

  Affiliation Department of Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital, Bern, Switzerland

  ⨯
• Passadakis Ploumis,

  Affiliation Department of Nephrology, University Hospital of Alexandroupoli, Alexandroupoli, Greece

  ⨯
• Spyridon Arampatzis

  * E-mail: spyridon.arampatzis@insel.ch

  Affiliation Department of Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital, Bern, Switzerland

  ⨯